These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

537 related items for PubMed ID: 4200675

  • 21. Hyaluronidase-induced inhibition of the insulinotropic action of sulfonylureas, leucine, and glucagon in rodent isolated pancreatic islets.
    Macchi IA, Zeytinoğlu FN.
    Horm Metab Res; 1976 Mar; 8(2):92-6. PubMed ID: 177348
    [Abstract] [Full Text] [Related]

  • 22. [Experimental study of glipizide. A comparison with other hypoglycemic sulfonamides (author's transl)].
    Loubatières AL, Loubatieres-Mariani MM, Alric R, Ribes G, Sorial G, Tarasco A.
    Diabete Metab; 1975 Mar; 1():13-21. PubMed ID: 824163
    [Abstract] [Full Text] [Related]

  • 23. A clinical study of the metabolic effect of a new oral hypoglycemic agent: glipizide.
    Iacono G, Ghionni A, Colucci M, Verde G, Caputo G.
    Int J Clin Pharmacol; 1974 Apr; 7(3):225-31. PubMed ID: 4850166
    [No Abstract] [Full Text] [Related]

  • 24. Therapeutical concentrations of tolbutamide, glibenclamide, gliclazide and gliquidone at different glucose levels: in vitro effects on pancreatic A- and B-cell function.
    Gregorio F, Ambrosi F, Cristallini S, Pedetti M, Filipponi P, Santeusanio F.
    Diabetes Res Clin Pract; 1992 Dec; 18(3):197-206. PubMed ID: 1289021
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Potentiating effects of combined usage of three sulfonylurea drugs on the occurrence of alloxan diabetes in rats.
    Katsumata K, Katsumata Y, Ozawa T, Katsumata K.
    Horm Metab Res; 1993 Feb; 25(2):125-6. PubMed ID: 8458609
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Therapy of diabetes in adults using Glibornurid. Results and clinical studies].
    Schöffling K, Mehnert H, Ewald W, Haupt E, Wicklmayr M, Beyer J, Nemeth N.
    Dtsch Med Wochenschr; 1973 May 04; 98(18):915-9. PubMed ID: 4633717
    [No Abstract] [Full Text] [Related]

  • 32. ["First" and "second" generation sulfonylureas: distinction or difference? (author's transl)].
    Balant L.
    Diabete Metab; 1978 Jun 04; 4(2):135-43. PubMed ID: 98364
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Oral management of uncomplicated maturity onset diabetes.
    Mashaly M, el-Ebrashy N, Higazi AM, Einen MA, Aziz MT.
    J Egypt Med Assoc; 1974 Jun 04; 57(7-8):288-97. PubMed ID: 4217809
    [No Abstract] [Full Text] [Related]

  • 35. Effect of tolbutamide, glyburide and glipizide administered supraspinally on CA3 hippocampal neuronal cell death and hyperglycemia induced by kainic acid in mice.
    Kim CH, Park SH, Sim YB, Kim SS, Kim SJ, Lim SM, Jung JS, Suh HW.
    Brain Res; 2014 May 20; 1564():33-40. PubMed ID: 24713348
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.